Update – 20 August 2021 The temporary suspension of the requirement for patients (or their representatives) to sign the reverse of NHS prescription forms or EPS tokens is due to end on 31 August 2021. In addition, the submission requirement of certain EPS tokens to the NHS Business Services Authority (NHSBSA) is also due to resume from 1 September. Whilst PSNC awaits...
In response to significant ongoing disruption to the supply of levothyroxine 12.5mcg tablets, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a short...
At the end of last week, the Department of Health and Social Care (DHSC) announced that due to ongoing COVID-19 pressures across all sectors, the requirement to publish renewed Pharmaceutical Needs Assessments (PNAs) will be suspended until October 2022 – an extra six months. The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013...
The March 2021 edition of PSNC’s Community Pharmacy News (CPN) is now available. This issue of CPN features: COVID-19: One year since lockdown; Distribution of COVID-19 tests; Changes to Pandemic Delivery Service; and Prescription charge increas...
A new Advanced service – the NHS community pharmacy COVID-19 lateral flow device distribution service – has been added to the NHS Community Pharmacy Contractual Framework (CPCF) today. This service, which pharmacy contractors can choose to provide, aims to improve access to asymptomatic COVID-19 testing by making lateral flow device (LFD) test kits readily available...
Recent Comments